Premark Pharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $957K

  • Investors
  • 1

Premark Pharma General Information

Description

Developer of novel therapeutic drugs designed to treat ophthalmic diseases. The company specializes in developing topical treatments for inflammatory diseases of the skin, eye, mucosae, and mucocutaneous surfaces, enabling doctors to cure patients suffering from unmet conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Christoph Merian-Ring 11
  • 4153 Reinach
  • Switzerland
+41 079
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Christoph Merian-Ring 11
  • 4153 Reinach
  • Switzerland
+41 079

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Premark Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 09-Jun-2022 $957K Completed Clinical Trials - Phase 3
1. Seed Round 07-Mar-2019 Completed Clinical Trials - Phase 3
To view Premark Pharma’s complete valuation and funding history, request access »

Premark Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Premark Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Premark Pharma Patents

Premark Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4687895-A1 Use of pimecrolimus for the treatment of dry eye in patients characterized by a corneal staining score of 4 or 5 on the oxford grading scale Pending 06-Apr-2023
WO-2024209038-A1 Use of pimecrolimus for the treatment of dry eye in patients characterized by a corneal staining score of 4 or 5 on the oxford grading scale Inactive 06-Apr-2023
EP-3972583-B1 Pimecrolimus ointment for treating moderate to severe blepharitis Active 21-May-2019
EP-3972583-C0 Pimecrolimus ointment for treating moderate to severe blepharitis Active 21-May-2019
ES-3067708-T3 Pimecrolimus ointment for treating moderate to severe blepharitis Active 21-May-2019 A61K31/436
To view Premark Pharma’s complete patent history, request access »

Premark Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Premark Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
To view Premark Pharma’s complete investors history, request access »

Premark Pharma FAQs

  • When was Premark Pharma founded?

    Premark Pharma was founded in 2018.

  • Where is Premark Pharma headquartered?

    Premark Pharma is headquartered in Reinach, Switzerland.

  • What is the size of Premark Pharma?

    Premark Pharma has 2 total employees.

  • What industry is Premark Pharma in?

    Premark Pharma’s primary industry is Drug Discovery.

  • Is Premark Pharma a private or public company?

    Premark Pharma is a Private company.

  • What is the current valuation of Premark Pharma?

    The current valuation of Premark Pharma is .

  • What is Premark Pharma’s current revenue?

    The current revenue for Premark Pharma is .

  • How much funding has Premark Pharma raised over time?

    Premark Pharma has raised $957K.

  • Who are Premark Pharma’s investors?

    has invested in Premark Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process